심장 매핑 시장 : 제품별, 적응 질환별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2021-2031년)

The global cardiac mapping market was valued at $2,625.0 million in 2021, and is projected to reach $4,572.17 million by 2031, registering a CAGR of 5.7% from 2022 to 2031.

Over the past ten years, interventional electrophysiology has advanced significantly. One of the most sophisticated methods used to collect and present the information obtained from an ECG is cardiac mapping. The technique involves identifying geographical and temporal distribution of cardiac electrical signals during a specific heartbeat. In recent years, innovative mapping methods have transformed the clinical electrophysiology laboratory and provided fresh insights to the mechanisms behind arrhythmias. In addition, there is a huge improvement in the resolution, three-dimensional spatial localization, and speed of acquisition of cardiac activity maps.

According to the Centers for Disease Control and Prevention, CDC, more than 454,000 hospitalizations with atrial fibrillation as the primary diagnosis happens each year in the U.S. This rise in incidence of cardiovascular diseases among all age groups owing to a sedentary lifestyle, rise in obesity, lack of physical fitness and stress, is expected to lead to sales of cardiac mapping systems on a large scale.

Furthermore, the growth of the cardiac mapping market is anticipated to be facilitated by the introduction of numerous cutting-edge diagnostic technologies by medical device companies, increase in the demand for accurate diagnosis of serious cardiac diseases, and availability of interventional cardiologists with the necessary training in developed economies.

The U.S. Department of Health & Human Services initiated a national campaign called 'Million Hearts', which aims to stop 1 million heart attacks and strokes in the next five years (from January 2022 to December 2026). It focuses on adopting a condensed list of priorities and goals that are supported by research and can enhance cardiovascular health for everyone. Thus, such more initiatives and funding provided by the government are expected to provide prevalence of factors causing the market growth.

In addition, rise in investment for research and development of the advanced and precise diagnostic tools by public and private players in the market with an aim to improve health care infrastructure and increase in adoption by the interventional cardiologists in hospitals are the key factors for the expansion of the cardiac mapping market. For instance, the development of the CardioInsight Noninvasive 3D Mapping System uses a proprietary, single-use, disposable multi-electrode vest to capture electrical signals from the body surface and displays interactive 3-D color maps including activation, composite, and phase maps.

However, the market is expected to be significantly constrained in the near future by factors, such as lack of awareness about these systems in developing nations, expensive price, and minor risks involved in the cardiac mapping operation.

The cardiac mapping market is segmented on the basis of product, indication, end user, and region. By product, it is divided into contact cardiac mapping systems and non-contact cardiac mapping systems. Further, the contact cardiac mapping systems segment is divided into electroanatomical mapping, basket catheter mapping, and traditional endocardial catheter mapping. On the basis of indication, the market is segmented into atrial fibrillation, atrial flutter, AVNRT, and others. According to end user, the market is segmented into hospitals, clinics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include Abbott Laboratories, Acutus Medical Inc., APN Healthcare, BioSig Technologies, Boston Bioscientific Corporation, EPMap Systems, Johnson And Johnson (Biosense Webster), Kardium Inc., Koninklijke Philips, Lepu Medical Technology, Medtronic Plc., MicroPort Scientific Corporation, and others.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiac mapping market analysis from 2021 to 2031 to identify the prevailing cardiac mapping market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the cardiac mapping market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global cardiac mapping market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End User

• Hospitals
• Clinics
• Others

By Product

• Non-contact Cardiac mapping systems
• Contact Cardiac mapping systems
  • Type
  • Electroanatomical mapping
  • Basket catheter mapping
  • Traditional endocardial catheter mapping

By Indication

• Atrial Fibrillation
• Atrial Flutter
• AVNRT
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest Of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest Of LAMEA
• Key Market Players
  • Abbott Laboratories
  • Acutus Medical Inc.
  • APN Healthcare
  • BioSig Technologies
  • Boston Bioscientific Corporation
  • EPMap Systems
  • Johnson and Johnson (Biosense Webster)
  • Kardium Inc.
  • Koninklijke Philips
  • Lepu Medical Technology
  • Medtronic Plc.
  • MicroPort Scientific Corporation

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market
• 3.7.Patent Landscape

CHAPTER 4: CARDIAC MAPPING MARKET, BY PRODUCT

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Contact Cardiac mapping systems
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market analysis by country
  • 4.2.4 Contact Cardiac mapping systems Cardiac Mapping Market by Type
    • 4.2.4.1 Electroanatomical mapping Market size and forecast, by region
    • 4.2.4.2 Basket catheter mapping Market size and forecast, by region
    • 4.2.4.3 Traditional endocardial catheter mapping Market size and forecast, by region
• 4.3 Non-contact Cardiac mapping systems
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market analysis by country

CHAPTER 5: CARDIAC MAPPING MARKET, BY INDICATION

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Atrial Fibrillation
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market analysis by country
• 5.3 Atrial Flutter
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market analysis by country
• 5.4 AVNRT
  • 5.4.1 Key market trends, growth factors and opportunities
  • 5.4.2 Market size and forecast, by region
  • 5.4.3 Market analysis by country
• 5.5 Others
  • 5.5.1 Key market trends, growth factors and opportunities
  • 5.5.2 Market size and forecast, by region
  • 5.5.3 Market analysis by country

CHAPTER 6: CARDIAC MAPPING MARKET, BY END USER

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 Hospitals
  • 6.2.1 Key market trends, growth factors and opportunities
  • 6.2.2 Market size and forecast, by region
  • 6.2.3 Market analysis by country
• 6.3 Clinics
  • 6.3.1 Key market trends, growth factors and opportunities
  • 6.3.2 Market size and forecast, by region
  • 6.3.3 Market analysis by country
• 6.4 Others
  • 6.4.1 Key market trends, growth factors and opportunities
  • 6.4.2 Market size and forecast, by region
  • 6.4.3 Market analysis by country

CHAPTER 7: CARDIAC MAPPING MARKET, BY REGION

• 7.1 Overview
  • 7.1.1 Market size and forecast
• 7.2 North America
  • 7.2.1 Key trends and opportunities
  • 7.2.2 North America Market size and forecast, by Product
    • 7.2.2.1 North America Contact Cardiac mapping systems Cardiac Mapping Market by Type
  • 7.2.3 North America Market size and forecast, by Indication
  • 7.2.4 North America Market size and forecast, by End User
  • 7.2.5 North America Market size and forecast, by country
    • 7.2.5.1 U.S.
    • 7.2.5.1.1 Market size and forecast, by Product
    • 7.2.5.1.2 Market size and forecast, by Indication
    • 7.2.5.1.3 Market size and forecast, by End User
    • 7.2.5.2 Canada
    • 7.2.5.2.1 Market size and forecast, by Product
    • 7.2.5.2.2 Market size and forecast, by Indication
    • 7.2.5.2.3 Market size and forecast, by End User
    • 7.2.5.3 Mexico
    • 7.2.5.3.1 Market size and forecast, by Product
    • 7.2.5.3.2 Market size and forecast, by Indication
    • 7.2.5.3.3 Market size and forecast, by End User
• 7.3 Europe
  • 7.3.1 Key trends and opportunities
  • 7.3.2 Europe Market size and forecast, by Product
    • 7.3.2.1 Europe Contact Cardiac mapping systems Cardiac Mapping Market by Type
  • 7.3.3 Europe Market size and forecast, by Indication
  • 7.3.4 Europe Market size and forecast, by End User
  • 7.3.5 Europe Market size and forecast, by country
    • 7.3.5.1 Germany
    • 7.3.5.1.1 Market size and forecast, by Product
    • 7.3.5.1.2 Market size and forecast, by Indication
    • 7.3.5.1.3 Market size and forecast, by End User
    • 7.3.5.2 France
    • 7.3.5.2.1 Market size and forecast, by Product
    • 7.3.5.2.2 Market size and forecast, by Indication
    • 7.3.5.2.3 Market size and forecast, by End User
    • 7.3.5.3 UK
    • 7.3.5.3.1 Market size and forecast, by Product
    • 7.3.5.3.2 Market size and forecast, by Indication
    • 7.3.5.3.3 Market size and forecast, by End User
    • 7.3.5.4 Italy
    • 7.3.5.4.1 Market size and forecast, by Product
    • 7.3.5.4.2 Market size and forecast, by Indication
    • 7.3.5.4.3 Market size and forecast, by End User
    • 7.3.5.5 Spain
    • 7.3.5.5.1 Market size and forecast, by Product
    • 7.3.5.5.2 Market size and forecast, by Indication
    • 7.3.5.5.3 Market size and forecast, by End User
    • 7.3.5.6 Rest of Europe
    • 7.3.5.6.1 Market size and forecast, by Product
    • 7.3.5.6.2 Market size and forecast, by Indication
    • 7.3.5.6.3 Market size and forecast, by End User
• 7.4 Asia-Pacific
  • 7.4.1 Key trends and opportunities
  • 7.4.2 Asia-Pacific Market size and forecast, by Product
    • 7.4.2.1 Asia-Pacific Contact Cardiac mapping systems Cardiac Mapping Market by Type
  • 7.4.3 Asia-Pacific Market size and forecast, by Indication
  • 7.4.4 Asia-Pacific Market size and forecast, by End User
  • 7.4.5 Asia-Pacific Market size and forecast, by country
    • 7.4.5.1 Japan
    • 7.4.5.1.1 Market size and forecast, by Product
    • 7.4.5.1.2 Market size and forecast, by Indication
    • 7.4.5.1.3 Market size and forecast, by End User
    • 7.4.5.2 China
    • 7.4.5.2.1 Market size and forecast, by Product
    • 7.4.5.2.2 Market size and forecast, by Indication
    • 7.4.5.2.3 Market size and forecast, by End User
    • 7.4.5.3 Australia
    • 7.4.5.3.1 Market size and forecast, by Product
    • 7.4.5.3.2 Market size and forecast, by Indication
    • 7.4.5.3.3 Market size and forecast, by End User
    • 7.4.5.4 India
    • 7.4.5.4.1 Market size and forecast, by Product
    • 7.4.5.4.2 Market size and forecast, by Indication
    • 7.4.5.4.3 Market size and forecast, by End User
    • 7.4.5.5 South Korea
    • 7.4.5.5.1 Market size and forecast, by Product
    • 7.4.5.5.2 Market size and forecast, by Indication
    • 7.4.5.5.3 Market size and forecast, by End User
    • 7.4.5.6 Rest of Asia-Pacific
    • 7.4.5.6.1 Market size and forecast, by Product
    • 7.4.5.6.2 Market size and forecast, by Indication
    • 7.4.5.6.3 Market size and forecast, by End User
• 7.5 LAMEA
  • 7.5.1 Key trends and opportunities
  • 7.5.2 LAMEA Market size and forecast, by Product
    • 7.5.2.1 LAMEA Contact Cardiac mapping systems Cardiac Mapping Market by Type
  • 7.5.3 LAMEA Market size and forecast, by Indication
  • 7.5.4 LAMEA Market size and forecast, by End User
  • 7.5.5 LAMEA Market size and forecast, by country
    • 7.5.5.1 Brazil
    • 7.5.5.1.1 Market size and forecast, by Product
    • 7.5.5.1.2 Market size and forecast, by Indication
    • 7.5.5.1.3 Market size and forecast, by End User
    • 7.5.5.2 Saudi Arabia
    • 7.5.5.2.1 Market size and forecast, by Product
    • 7.5.5.2.2 Market size and forecast, by Indication
    • 7.5.5.2.3 Market size and forecast, by End User
    • 7.5.5.3 South Africa
    • 7.5.5.3.1 Market size and forecast, by Product
    • 7.5.5.3.2 Market size and forecast, by Indication
    • 7.5.5.3.3 Market size and forecast, by End User
    • 7.5.5.4 Rest of LAMEA
    • 7.5.5.4.1 Market size and forecast, by Product
    • 7.5.5.4.2 Market size and forecast, by Indication
    • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

• 9.1 Abbott Laboratories
  • 9.1.1 Company overview
  • 9.1.2 Company snapshot
  • 9.1.3 Operating business segments
  • 9.1.4 Product portfolio
  • 9.1.5 Business performance
  • 9.1.6 Key strategic moves and developments
• 9.2 Acutus Medical Inc.
  • 9.2.1 Company overview
  • 9.2.2 Company snapshot
  • 9.2.3 Operating business segments
  • 9.2.4 Product portfolio
  • 9.2.5 Business performance
  • 9.2.6 Key strategic moves and developments
• 9.3 APN Healthcare
  • 9.3.1 Company overview
  • 9.3.2 Company snapshot
  • 9.3.3 Operating business segments
  • 9.3.4 Product portfolio
  • 9.3.5 Business performance
  • 9.3.6 Key strategic moves and developments
• 9.4 BioSig Technologies
  • 9.4.1 Company overview
  • 9.4.2 Company snapshot
  • 9.4.3 Operating business segments
  • 9.4.4 Product portfolio
  • 9.4.5 Business performance
  • 9.4.6 Key strategic moves and developments
• 9.5 Boston Bioscientific Corporation
  • 9.5.1 Company overview
  • 9.5.2 Company snapshot
  • 9.5.3 Operating business segments
  • 9.5.4 Product portfolio
  • 9.5.5 Business performance
  • 9.5.6 Key strategic moves and developments
• 9.6 EPMap Systems
  • 9.6.1 Company overview
  • 9.6.2 Company snapshot
  • 9.6.3 Operating business segments
  • 9.6.4 Product portfolio
  • 9.6.5 Business performance
  • 9.6.6 Key strategic moves and developments
• 9.7 Johnson and Johnson (Biosense Webster)
  • 9.7.1 Company overview
  • 9.7.2 Company snapshot
  • 9.7.3 Operating business segments
  • 9.7.4 Product portfolio
  • 9.7.5 Business performance
  • 9.7.6 Key strategic moves and developments
• 9.8 Kardium Inc.
  • 9.8.1 Company overview
  • 9.8.2 Company snapshot
  • 9.8.3 Operating business segments
  • 9.8.4 Product portfolio
  • 9.8.5 Business performance
  • 9.8.6 Key strategic moves and developments
• 9.9 Koninklijke Philips
  • 9.9.1 Company overview
  • 9.9.2 Company snapshot
  • 9.9.3 Operating business segments
  • 9.9.4 Product portfolio
  • 9.9.5 Business performance
  • 9.9.6 Key strategic moves and developments
• 9.10 Lepu Medical Technology
  • 9.10.1 Company overview
  • 9.10.2 Company snapshot
  • 9.10.3 Operating business segments
  • 9.10.4 Product portfolio
  • 9.10.5 Business performance
  • 9.10.6 Key strategic moves and developments
• 9.11 Medtronic Plc.
  • 9.11.1 Company overview
  • 9.11.2 Company snapshot
  • 9.11.3 Operating business segments
  • 9.11.4 Product portfolio
  • 9.11.5 Business performance
  • 9.11.6 Key strategic moves and developments
• 9.12 MicroPort Scientific Corporation
  • 9.12.1 Company overview
  • 9.12.2 Company snapshot
  • 9.12.3 Operating business segments
  • 9.12.4 Product portfolio
  • 9.12.5 Business performance
  • 9.12.6 Key strategic moves and developments